Invention Grant
- Patent Title: Anti-myostatin antibodies and methods of use
-
Application No.: US16065192Application Date: 2016-12-22
-
Publication No.: US11359009B2Publication Date: 2022-06-14
- Inventor: Yoshinao Ruike , Taichi Kuramochi
- Applicant: Chugai Seiyaku Kabushiki Kaisha
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Nixon & Vanderhye P.C.
- Priority: JPJP2015-253346 20151225
- International Application: PCT/JP2016/088302 WO 20161222
- International Announcement: WO2017/110981 WO 20170629
- Main IPC: C07K16/22
- IPC: C07K16/22 ; A61P21/00 ; A61K39/00

Abstract:
The invention provides anti-myostatin antibodies and methods of using the same. In some embodiments, an isolated anti-myostatin antibody of the present invention binds to mature myostatin, and uptake of the antibody into cells is enhanced when complexed with the antigen. The invention also provides isolated nucleic acids encoding an anti-myostatin antibody of the present invention. The invention also provides host cells comprising a nucleic acid of the present invention. The invention also provides a method of producing an antibody comprising culturing a host cell of the present invention so that the antibody is produced. Anti-myostatin antibodies of the present invention may be for use as a medicament. Anti-myostatin antibodies of the present invention may be for use in treating a muscle wasting disease. Anti-myostatin antibodies of the present invention may be for use in increasing mass of muscle tissue. Anti-myostatin antibodies of the present invention may be for use in increasing strength of muscle tissue.
Public/Granted literature
- US20190002548A1 ANTI-MYOSTATIN ANTIBODIES AND METHODS OF USE Public/Granted day:2019-01-03
Information query